Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grownin vitro

  • Arlen R. Severson
  • Ronald T. Ingram
  • Lorraine A. Fitzpatrick
Cellular Models


Atherosclerotic lesions are composed of cellular elements that have migrated from the vessel lumen and wall to form the cellular component of the developing plaque. The cellular elements are influenced by various growth-regulatory molecules, cytokines, chemoattractants, and vasoregulatory molecules that regulate the synthesis of the extracellular matrix composing the plaque. Because vascular smooth muscle cells (VSMC) constitute the major cellular elements of the atherosclerotic plaque and are thought to be responsible for the extracellular matrix that becomes calcified in mature plaques, immunostaining for collagenous and noncollagenous proteins typically associated with bone matrix was conducted on VSMC grownin vitro. VSMC obtained from human aorta were grown in chambers on glass slides and immunostained for procollagen type I, bone sialoprotein, osteonectin, osteocalcin, osteopontin, decorin, and biglycan. VSMC demonstrated an intense staining for procollagen type I, and a moderately intense staining for the noncollagenous proteins, bone sialoprotein and osteonectin, two proteins closely associated with bone mineralization. Minimal immunostaining was noted for osteocalcin, osteopontin, decorin, and biglycan. The presence in VSMC of collagenous and noncollagenous proteins associated with bone mineralization suggest that the smooth muscle cells in the developing atherosclerotic plaque play an important role in the deposition of the extracellular matrix involved in calcification of developing lesions.

Key words

atherosclerosis calcification extracellular matrix proteins collagen noncollagenous proteins 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abraham, P. A.; Smith, D. W.; Carnes, W. H. Synthesis of soluble elastin by aortic medial cells in culture. Biochem. Biophys. Res. Commun. 58:597–604; 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Ang, A. K.; Tachas, G.; Campbell, J. H., et al. Collagen synthesis by cultured rabbit aortic smooth muscle cells: Alteration with phenotype. Biochem. J. 265:461–469; 1990.PubMedGoogle Scholar
  3. 3.
    Asundi, V.; Cowan, K.; Matzura, D., et al. Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells. Eur. J. Cell Biol. 52:98–104; 1990.PubMedGoogle Scholar
  4. 4.
    Bianco, P.; Fisher, L. W.; Young, M. F., et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38:1549–1563; 1990.PubMedGoogle Scholar
  5. 5.
    Bianco, P.; Riminucci, M.; Silvestrini, G., et al. Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. J. Histochem. Cytochem. 41:193–203; 1993.PubMedGoogle Scholar
  6. 6.
    Bolander, M. E.; Robey, P. G.; Fisher, L. W., et al. Monoclonal antibodies against osteonectin show conservation of epitopes across species. Calcif. Tissue Int. 45:74–80; 1989.PubMedCrossRefGoogle Scholar
  7. 7.
    Bostrom, K.; Watson, K. E.; Horn, S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800–1809; 1993.PubMedGoogle Scholar
  8. 8.
    Burleigh, M. C.; Briggs, A. D.; Lendon, C. L., et al. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: Span-wise variation. Atherosclerosis 96:71–81; 1992.PubMedCrossRefGoogle Scholar
  9. 9.
    Campbell, J. H.; Kalevitch, S. G.; Rennick, R. E., et al. Extracellular matrix-smooth muscle phenotype modulation by macrophages. Ann. NY Acad. Sci. 598:159–166; 1990.PubMedCrossRefGoogle Scholar
  10. 10.
    Carlström, D.; Engfeldt, B.; Engström, B., et al. Studies on the chemical composition of normal and abnormal blood vessel walls. I. Chemical nature of vascular calcified deposits. Lab. Invest. 2:325–335; 1953.PubMedGoogle Scholar
  11. 11.
    Chen, J. K.; Shapiro, H. S.; Sodek, J. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J. Bone Miner. Res. 7:987–997; 1992.PubMedGoogle Scholar
  12. 12.
    Chen, J. K.; Shapiro, H. S.; Wrabam, J. L., et al. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133–143; 1991.PubMedGoogle Scholar
  13. 13.
    Fisher, L. W. The nature of proteoglycans in bone. In: Butler, E. T., ed. The chemistry and biology of mineralized tissues. Birmingham, AL: EBSCO Media; 1985:188–196.Google Scholar
  14. 14.
    Fisher, L. W.; Hawkins, G. R.; Tuross, N., et al. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J. Biol. Chem. 262:9702–9708; 1987.PubMedGoogle Scholar
  15. 15.
    Fisher, L. W.; Termine, J. D.; Young, M. F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264:4571–4576; 1989.PubMedGoogle Scholar
  16. 16.
    Fisher, L. W.; Whitson, S. W.; Avioli, L. V., et al. Matrix sialoprotein of developing bone. J. Biol. Chem. 258:12723–12727; 1983.PubMedGoogle Scholar
  17. 17.
    Giachelli, C. M.; Bae, N.; Almeida, M., et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92:1686–1696; 1992.Google Scholar
  18. 18.
    Gibbons, G. H.; Dzau, V. J. The emerging concept of vascular remodeling. N. Engl. J. Med. 330:1431–1438; 1994.PubMedCrossRefGoogle Scholar
  19. 19.
    Gorski, J. P. Acidic phosphoproteins from bone matrix: A structural rationalization of their role in mineralization. Calcif. Tissue Int. 50:391–396; 1992.PubMedCrossRefGoogle Scholar
  20. 20.
    Herman, I. M. Endothelial cell matrices modulate smooth muscle growth, contractile phenotype and sensitivity to heparin. Haemostasis 20:166–177; 1990.PubMedGoogle Scholar
  21. 21.
    Hirota, S.; Imakita, M.; Kohri, K., et al. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification. Am. J. Pathol. 143:1003–1008; 1993.PubMedGoogle Scholar
  22. 22.
    Ikeda, T.; Shirasawa, T.; Esaki, Y., et al. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 92:2814–2820; 1993.PubMedGoogle Scholar
  23. 23.
    Ingram, R.; Clarke, B.; Fisher, L., et al. Distribution of noncollagenous matrix proteins in the extracellular matrix of adult human bone: Evidence of anatomical and functional heterogeneity. J. Bone Miner. Res. 8:1019–1029; 1993.PubMedCrossRefGoogle Scholar
  24. 24.
    Kasai, R.; Avioli, L. V.; Noguchi, A., et al. Distribution and regulation of an anti-proBGP cross-reacting protein in human serum, osteosarcoma and normal cells, and fetal bone. J. Bone Min. Res. 4:S247; 1989.Google Scholar
  25. 25.
    Kaufmann, J.; Jorgensen, R. W.; Martin, B. M., et al. Monocyte activation by smooth muscle cell-derived matrices. Atherosclerosis 85:113–125; 1990.PubMedCrossRefGoogle Scholar
  26. 26.
    Lian, J. B.; Tassinari, M.; Glowacki, J. Resorption of implanted bone prepared from normal and warfarin-treated rats. J. Clin. Invest. 73:1223–1226; 1984.PubMedGoogle Scholar
  27. 27.
    Liptay, M. J.; Parks, W. C.; Mecham, R. P., et al. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91:588–594; 1993.PubMedGoogle Scholar
  28. 28.
    Majesky, M. W.; Lindner, V.; Twardzik, D. R., et al. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:904–910; 1991.PubMedGoogle Scholar
  29. 29.
    Majors, A. K.; Ehrhart, L. A. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp. Cell Res. 200:168–174; 1992.PubMedCrossRefGoogle Scholar
  30. 30.
    McKee, M.; Glimcher, M.; Nanci, A. High resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia. Anat. Rec. 234:479–492; 1992.PubMedCrossRefGoogle Scholar
  31. 31.
    Murata, K.; Motoyama, T. Collagen species in various sized human arteries and their changes with intimal proliferation. Artery 17:96–106; 1990.PubMedGoogle Scholar
  32. 32.
    Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 363:801–809; 1993.CrossRefGoogle Scholar
  33. 33.
    Shanahan, C. M.; Cary, N. R. B.; Metcalfe, J. C., et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93:2393–2402; 1994.PubMedGoogle Scholar
  34. 34.
    Stary, H. C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur. Heart J. 11 (Suppl. E):3–19; 1990.PubMedGoogle Scholar
  35. 35.
    Tabas, I.; Li, Y.; Brocia, R. W., et al. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix: A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268:20419–20432; 1993.PubMedGoogle Scholar
  36. 36.
    Tan, E. M.; Glassberg, E.; Olsen, D. R., et al. Extracellular matrix gene expression by human endothelial and smooth muscle cells. Matrix 11:380–387; 1991.PubMedGoogle Scholar
  37. 37.
    Termine, J. D.; Kleinman, H. K.; Whitson, S. W., et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26:99–105; 1981.PubMedCrossRefGoogle Scholar
  38. 38.
    Thie, M.; Harrach, B.; Schonherr, E., et al. Responsiveness of aortic smooth muscle cells to soluble growth mediators is influenced by cell-matrix contact. Arterioscler. Thromb. 13:994–1004; 1993.PubMedGoogle Scholar
  39. 39.
    Watson, K. E.; Bostrom, K.; Ravindranath, R., et al. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93:2106–2113; 1994.PubMedCrossRefGoogle Scholar

Copyright information

© Society for In Vitro Biology 1995

Authors and Affiliations

  • Arlen R. Severson
    • 1
    • 2
  • Ronald T. Ingram
    • 2
  • Lorraine A. Fitzpatrick
    • 2
  1. 1.Department of Anatomy and Cell Biology, School of MedicineUniversity of MinnesotaDuluth
  2. 2.Endocrine Research Unit, Department of Internal MedicineMayo Clinic and Mayo FoundationRochester

Personalised recommendations